Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/E ratio is N/A as of 2026-10-06T20:06:20.456Z.
Calculation as of: 2026-10-06T20:06:20.456Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 5d6bd3278d76725a85d4cb05495e45b99d0fd89b23371e3701c8289362793e8f
PE RATIO
N/A
Market Cap
$761.37M
PE Ratio
161.98
TTM Avg
129.79
3Y Avg
309.15
5Y Avg
358.87
Market Cap
$777.34M
PE Ratio
N/A
TTM Avg
12.44
3Y Avg
5.97
5Y Avg
5.97
| NAME | MARKET CAP | PE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Design Therapeutics, Inc. (DSGN) | $747.61M | N/A | N/A | N/A | N/A |
| Apnimed, Inc. (APMD)vs › | $742.70M | N/A | N/A | N/A | N/A |
| Attovia Therapeutics, Inc. (ATTO)vs › | $753.02M | N/A | N/A | N/A | N/A |
| Mesa Laboratories, Inc. (MLAB)vs › | $761.37M | 161.98 | 129.79 | 309.15 | 358.87 |
| Sana Biotechnology, Inc. (SANA)vs › | $765.30M | N/A | N/A | N/A | N/A |
| Candel Therapeutics, Inc. (CADL)vs › | $723.18M | N/A | N/A | N/A | N/A |
| Achieve Life Sciences, Inc. (ACHV)vs › | $721.69M | N/A | N/A | N/A | N/A |
| Geron Corporation (GERN)vs › | $776.24M | N/A | 973.22 | 973.22 | 973.22 |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $777.34M | N/A | 12.44 | 5.97 | 5.97 |
| Varex Imaging Corporation (VREX)vs › | $778.01M | 35.24 | 35.24 | 21.52 | 29.94 |
Trailing P/E
N/A
Forward P/E
N/A
Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.
Calculation:
Current Price
$11.97
Forward EPS (Est.)
$-1.32
Forward P/E
N/A
Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
